Immatics N.V.

IMTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.20-1.50%

2026-10-30

Financials

Valuation Metrics

Immatics N.V.'s Market Cap is $984M. At end of 2025 it was $584M. Ranked #2398 of 3,116 in US market (top 77%), #972 of 1,470 on NASDAQ (top 66%), #178 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 67%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$984M	US#2,398/3,116 Sec#178/265
Revenue	$46M	US#2,753/3,116 Sec#150/265
Net Income	$-233M	US—/3,116 Sec—/265
Total Assets	$570M	US#2,712/3,116 Sec#145/265
Net Assets	$469M	US#2,262/3,116 Sec#112/265
Value
P/B	2.10x	US#1,391/3,116 Sec#70/265
P/S	21.21x	US#2,865/3,116 Sec#148/265
FCF Yield	-24.11%	US—/3,116 Sec—/265
Profitability
ROE	-49.73%	US#2,674/3,116 Sec#158/265
ROA	-40.91%	US#2,947/3,116 Sec#192/265
Op. Margin	-552.35%	US#2,786/3,116 Sec#155/265
Revenue Growth	-68.39%	US#2,712/3,116 Sec#169/265
Financial Health
Debt Ratio	21.55%	US#244/3,116 Sec#83/265
Total Debt	$17M	US#2,774/3,116 Sec#192/265
FCF	$-237M	US#2,818/3,116 Sec#223/265
Cash	$273M	US#1,485/3,116 Sec#87/265
Current Ratio	7.54x	US#333/3,116 Sec#102/265
Performance
1Y Return	-30.90%	US#2,604/3,116 Sec#202/265
1M Return	-18.00%	US#2,608/3,116 Sec#186/265
From 52W High	-41.98%	US#2,330/3,116 Sec#165/265
1Y MDD	-43.30%	US#2,104/3,116 Sec#137/265
Trading
Volume	1,660,212 shares	US#1,102/3,116 Sec#122/265
Trading Value	$12M	US#2,230/3,116 Sec#179/265
Per Share
EPS	$-1.71	US—/3,116 Sec—/265
BPS	$3.43	US#2,422/3,116 Sec#155/265